[Headache. Current status of research and treatment].
The starting point for German headache research and clinical education was the engagement of D. Soyka in the 1970s, which enabled the foundation of the German Headache Society (DMKG) on 28 June 1979 and, some years later, the founding congress of the International Headache Society (IHS) in Munich 1982. As a result of these activities, in 1988 the first international classification of headache disorders was published. This classification was one of the major milestones in the development of basic as well as clinical headache research. In the following years, epidemiological studies all over the world showed a 1-year prevalence for headache of approximately 60%, making headaches one of the most frequent medical complaints. Basic research showed an involvement of serotonergic mechanisms in migraine pain and triptans were one of the first drugs designed to influence these mechanisms. Functional brain imaging studies in migraine patients further showed a cyclic modulation of the activity of brainstem areas independent of the current pain state. Various research groups were involved in the clarification of the role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache. A specific development in the German headache scene is the establishment of integrated headache centers and reflects the primarily multimodal treatment approach in Germany which contrasts with the settings in other countries. These successful developments are increasingly being undermined by the fact that the low financial support of headache research, for example, by the German science council is causing a decreasing interest in headache research, with the consequence that the clinical education of students as well as young medical doctors shows increasing deficits. The consequence for the future will be a deficit in the clinical care of the population.
Neurologische Klinik, Klinikum Großhadern, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland. andreas.straube@med.uni-muenchen.de.
A
A
Straube
Migräne- und Kopfschmerzklinik Königstein, Königstein, Deutschland.
C
C
Gaul
D035843:Biomedical Research / Q000193:education; D015740:Calcitonin Gene-Related Peptide / Q000502:physiology; D003131:Combined Modality Therapy; D003431:Cross-Cultural Comparison; D003430:Cross-Sectional Studies; D019033:Delivery of Health Care, Integrated; D004503:Education, Medical, Graduate; D005544:Forecasting; D020773:Headache Disorders / Q000145:classification / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008881:Migraine Disorders / Q000145:classification / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D012955:Societies, Medical
D015740:Calcitonin Gene-Related Peptide
Classification, headaches; Medical education, clinical; Medical education, undergraduate; Migraine; Research, clinical